Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe

Human rabies vaccines have been shown to induce partial protection against members of phylogroup I bat lyssaviruses. Here, we investigated the capacity of a widely used rabies inactivated vaccine (Rabisin, Boehringer-Ingelheim) for veterinary use to cross-protect mice experimentally infected with Eu...

Descripción completa

Detalles Bibliográficos
Autores principales: Servat, Alexandre, Wasniewski, Marine, Cliquet, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832384/
https://www.ncbi.nlm.nih.gov/pubmed/31614675
http://dx.doi.org/10.3390/v11100936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832384/
https://www.ncbi.nlm.nih.gov/pubmed/31614675
http://dx.doi.org/10.3390/v11100936

Ejemplares similares